Current Report Filing (8-k)
December 08 2021 - 4:29PM
Edgar (US Regulatory)
0000867028
false
0000867028
2021-11-28
2021-11-28
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
DC 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date
of Report (Date of earliest event reported): November 28, 2021
FOMO
CORP.
(Exact
name of Registrant as specified in its Charter)
california
|
|
001-13126
|
|
83-3889101
|
(State
or other jurisdiction
of
incorporation)
|
|
(Commission
File
No.)
|
|
(IRS
Employer
Identification
No.)
|
1
E Erie St, Ste 525 Unit #2250, Chicago, IL 60611
(Address
of principal executive offices)
(630)
286-9560
(Registrant’s
Telephone Number)
(Former
name or address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):
☐
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
☐
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
☐
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
☐
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class
|
|
Trading
symbol(s)
|
|
Name
of each exchange on which registered
|
Common
|
|
FOMC
|
|
OTC
Pink
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405)
or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2) ☒
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act
FOMO
CORP. is referred to herein as “FOMO”, “the Company”, “we”, or “us”.
Item
8.01 Other Items.
On
November 28, 2021, Himalaya Technologies, Inc. a/k/a Homeland Resources Ltd. (OTC: HMLA; https://www.himalayatechnologies.com/),
a minority-owned subsidiary of FOMO (https://www.fomoworldwide.com/), purchased 13,883,812 shares of GenBio, Inc. (“GenBio”;
https://genbioinc.com/) common stock using consideration of 99,686 Himalaya Series B preferred shares, representing 19.9% ownership
of GenBio. The Companies intend to collaborate on nutraceutical products offering anti-inflammatory and reduced blood pressure applications
including powders, enhanced honey extracts, droplets and canned beverages under the brands “FOMO” and others.
Item
9.01. Exhibits
(a)
Exhibits. The following exhibits are filed with this Current Report on Form 8-K:
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
|
FOMO
CORP.
|
|
|
Date:
December 8, 2021
|
By:
|
/s/
Vikram Grover
|
|
|
Vikram
Grover
|
|
|
Chief
Executive Officer
|